SPDR S&P Telecom ETF (XTL)

NYSEArca - NYSEArca Real Time Price. Currency in USD
62.53-0.68 (-1.08%)
At close: 4:00 PM EDT
People also watch:
  • PR Newswire16 days ago

    XTL Biopharmaceuticals Announces New Patent Filing in U.S. for Lupus Drug hCDR1

    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company developing its lead product for the treatment of lupus, today announced that it has filed a new patent application with the U.S. Patent and Trademark Office to protect doses of hCDR1 lower than 0.5 mg weekly, in the treatment of Systemic Lupus Erythematosus (SLE). The new patent application is based on clinical evidence that lower doses of hCDR1 may be as efficient, or in some instances more efficient, than the higher doses previously tested in the treatment of SLE. "We are pleased to expand the intellectual property assets around hCDR1, based on clinical data showing hCDR1 may be effective at doses lower than the 0.5 mg weekly, which has shown statistically significant efficacy as compared to placebo in a prior Phase 2 study," said Josh Levine, CEO of XTL.

  • MarketWatch19 days ago

    More cheer for the bulls as tech stocks, financials take the baton

    One worry about the U.S. stock market has been that its stars have been defensive sectors. That concern now may be fading, as analysts cheer the recent strength shown by tech, financials and other “cyclical” ...

  • Dow ETF Treads Water As Key Blue Chips Post Results That Lack Salt
    Investor's Business Dailylast month

    Dow ETF Treads Water As Key Blue Chips Post Results That Lack Salt

    Investors eye the start of the U.S. Federal Reserve's two-day policy meeting.